The implementation date of the highly anticipated 2025 Local Coverage Determinations (LCDs) for skin substitutes has been postponed until 4/13/2025, leaving providers and patients in a holding pattern. What does this delay really mean for your practice, and how do Medicare Administrative Contractors (MACs) historically approach such transitions?
Join us for an expert panel discussion featuring three distinguished speakers who will provide comprehensive insights into both current requirements and future changes.
Featured Speakers:
New Focus Points
MAC Perspectives on Coverage Transitions
What to Expect From Medicare and the MACs During the Delay
Advocating For or Against the LCD
Preparing Your Practice Now
Continuing Core Topics
Coding Best Practices
Product-Specific Guidance
Avoiding Common Pitfalls
Extended Q&A Session
Don’t miss this essential update on the current and future state of skin substitute coverage. Whether you’re looking for clarity on immediate coding practices or guidance on how to shape the LCD’s final form, this webinar provides the insights you need to stay ahead.
From the town of Ísafjörður in northwest Iceland, Kerecis develops, manufactures, and distributes patented fish-skin medical devices that support soft tissue regeneration in the body, with regulatory clearance in the United States, Europe, and beyond.
MariGen Compact is intact fish skin that’s been fragmented into small units (≤ 2.0 mm) and then compressed into a compact disc format.
It offers the same clinical benefits as Kerecis’ Micro variation, while enhancing ease of use for wound-care specialists.
Stay tuned to learn more!
SurgiClose Compact is intact fish skin that’s been fragmented into small units (≤ 2.0 mm) and then compressed into a compact disc format.
It offers the same clinical benefits as Kerecis’ Micro variation, while enhancing ease of use for surgeons.
Stay tuned to learn more!
